A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.